HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.

Abstract
Despite its potency, the wider use of immunotherapy for B cell malignancies is hampered by the lack of well-defined tumor-specific Ags. In this study, we demonstrate that an evolutionarily conserved 37-kDa immature laminin receptor protein (OFA-iLRP), a nonimmunogenic embryonic Ag expressed by a variety of tumors, is rendered immunogenic if targeted to the APCs using the CCR6 ligands MIP3alpha/CCL20 and mDF2beta. The CCR6 targeting facilitated efficient Ag cross-presentation and induction of tumor-neutralizing CTLs. Although the Ag targeting alone, without activation of dendritic cells (DCs), is proposed to induce tolerance, and MIP3alpha does not directly activate DCs, the MIP3alpha-based vaccine efficiently induced protective and therapeutic antitumor responses. The responses were as strong as those elicited by the OFA-iLRP fusions with moieties that activated DCs and Th1-type cytokine responses, mDF2beta, or mycobacterial Hsp70 Ag. Although the same cDNA encodes the dimerized high-affinity mature 67-kDa mLRP that is expressed in normal tissues to stabilize the binding of laminin to cell surface integrins, the vaccines expressing OFA-iLRP elicited long-term protective CD8(+) T cell-mediated memory responses against syngeneic B cell lymphoma, indicating the potential application of these simple vaccines as preventive and therapeutic formulations for human use.
AuthorsArya Biragyn, Roberta Schiavo, Purevdorj Olkhanud, Kenya Sumitomo, Alan King, Megan McCain, Fred E Indig, Giovanni Almanzar, Dolgor Baatar
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 179 Issue 2 Pg. 1381-8 (Jul 15 2007) ISSN: 0022-1767 [Print] United States
PMID17617631 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antigens, Neoplasm
  • CCL20 protein, mouse
  • CCR6 protein, mouse
  • Cancer Vaccines
  • Chemokine CCL20
  • Chemokines, CC
  • Macrophage Inflammatory Proteins
  • Receptors, CCR6
  • Receptors, Chemokine
  • Receptors, Laminin
  • oncofetal antigens
Topics
  • Animals
  • Antigen Presentation (immunology)
  • Antigen-Presenting Cells (immunology)
  • Antigens, Neoplasm (genetics, immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cancer Vaccines (immunology, therapeutic use)
  • Chemokine CCL20
  • Chemokines, CC (immunology)
  • Cloning, Molecular
  • Cytotoxicity, Immunologic
  • Female
  • Lymphoma, B-Cell (immunology, therapy)
  • Macrophage Inflammatory Proteins (immunology)
  • Mice
  • Microscopy, Confocal
  • Receptors, CCR6
  • Receptors, Chemokine (immunology)
  • Receptors, Laminin (genetics, immunology)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: